This website is intended for healthcare professionals

Trastuzumab

Pharmacotherapeutics of capecitabine and trastuzumab in the treatment of metastatic breast cancer

Breast cancer begins as a local disease but it can metastasise to the lymph glands and then to distant organs, with common metastatic sites being the lungs, liver and bones (Weigelt et al, 2005)....

Intravenous versus subcutaneous trastuzumab: an economic and patient perspective

Until December 2013, trastuzumab, licensed for the treatment of patients with Her2-positive early or metastatic breast cancer, was available as a powder for reconstitution before intravenous...

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP